Epidemiology of soy and cancer: perspectives and directions
- PMID: 7884555
- DOI: 10.1093/jn/125.3_Suppl.709S
Epidemiology of soy and cancer: perspectives and directions
Abstract
Previous epidemiologic studies of the effects of soy protein on cancer risk have been limited by small variations in soy intake, inability to separate soy from other dietary variables and difficulties inherent in relating dietary intake to the development of cancer several decades later. As a result, although existing data suggest that soy protein may be protective for cancer risk, results are overall inconclusive. There is also evidence that soy products may affect risk factors for cancer, such as endogenous hormone levels. Preliminary data from our group indicate that young Adventist women who are vegetarians with high soy intake and a lower risk of breast cancer may have higher levels of an adrenal androgen, dehydroepiandrosterone sulfate. Other groups have noted that soy protein may be associated with alterations in the regulation and binding of ovarian hormones. Additional studies examining effects of soy protein on risk factors for cancer would help, not only in delineating mechanisms of cancer development, but also in designing dietary programs aimed at cancer prevention.
Similar articles
-
Incorporating soy proteins into baked products for use in clinical studies.J Nutr. 1995 Mar;125(3 Suppl):666S-674S. doi: 10.1093/jn/125.3_Suppl.666S. J Nutr. 1995. PMID: 7884549 Review.
-
Modern applications for an ancient bean: soybeans and the prevention and treatment of chronic disease.J Nutr. 1995 Mar;125(3 Suppl):567S-569S. doi: 10.1093/jn/125.3_Suppl.567S. J Nutr. 1995. PMID: 7884533 Review.
-
Soy and experimental cancer: animal studies.J Nutr. 1995 Mar;125(3 Suppl):698S-708S. doi: 10.1093/jn/125.suppl_3.698S. J Nutr. 1995. PMID: 7884554 Review.
-
Soy: a complete source of protein.Am Fam Physician. 2009 Jan 1;79(1):43-7. Am Fam Physician. 2009. PMID: 19145965
-
The evidence for soybean products as cancer preventive agents.J Nutr. 1995 Mar;125(3 Suppl):733S-743S. doi: 10.1093/jn/125.3_Suppl.733S. J Nutr. 1995. PMID: 7884559 Review.
Cited by
-
Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones.J Neurooncol. 2006 Sep;79(2):135-42. doi: 10.1007/s11060-006-9126-0. Epub 2006 Apr 6. J Neurooncol. 2006. PMID: 16598420
-
Effect of combination treatment of rapamycin and isoflavones on mTOR pathway in human glioblastoma (U87) cells.Neurochem Res. 2010 Jul;35(7):986-93. doi: 10.1007/s11064-010-0142-2. Epub 2010 Feb 23. Neurochem Res. 2010. PMID: 20177775
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials